Literature DB >> 20665481

Retroperitoneal endoscopic adrenalectomy is safe and effective.

J M J Schreinemakers1, G J Kiela, G D Valk, M R Vriens, I H M Borel Rinkes.   

Abstract

BACKGROUND: The aim of this study was to review an experience with retroperitoneal endoscopic adrenalectomy (REA). This is the procedure of choice for adrenal tumours at this institution.
METHODS: Between 1997 and 2008, 112 REAs were performed in a single university centre. Data were retrieved retrospectively from a prospectively collected database, including information on patient demographics, surgical procedure, complications and hospital stay.
RESULTS: One hundred and twelve REAs were carried out successfully in 105 patients, including seven bilateral adrenalectomies. Thirty-nine patients with unilateral adrenal disease had a phaeochromocytoma, of whom 16 had multiple endocrine neoplasia syndrome type 2, 21 patients had Cushing's disease and 20 had Conn's disease. Median body mass index was 27 (interquartile range 23-29) kg/m(2). The median duration of unilateral operations was 100 (90-130) min with a median blood loss of 5 ml. Median tumour size was 3.1 (2.0-4.4) cm. Conversion from REA to open surgery was needed in two patients. Seven patients experienced postoperative complications (2 major, 5 minor). One patient needed a reoperation. The median postoperative hospital stay was 3 days. A learning curve with a significant decrease in operating time was observed over the years.
CONCLUSION: REA appears to be a safe and effective surgical technique for adrenal gland tumours up to 6 cm in diameter, with a minimal complication rate.
Copyright © 2010 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 20665481     DOI: 10.1002/bjs.7191

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  5 in total

1.  Retroperitoneoscopic Adrenalectomy in Obese Patients: Is It Suitable?

Authors:  Pavel Zonča; Marek Bužga; Peter Ihnát; Lubomír Martínek
Journal:  Obes Surg       Date:  2015-07       Impact factor: 4.129

2.  Ten year experience of retroperitoneal laparoscopic resection for pheochromocytomas: A dual-centre study of 72 cases.

Authors:  Aude de Fourmestraux; Laurent Salomon; Claude-Clément Abbou; Philippe Grise
Journal:  World J Urol       Date:  2014-09-11       Impact factor: 4.226

3.  Laparoscopic anterior versus endoscopic posterior approach for adrenalectomy: a shift to a new golden standard?

Authors:  O M Vrielink; K P Wevers; J W Kist; I H M Borel Rinkes; P H J Hemmer; M R Vriens; J de Vries; S Kruijff
Journal:  Langenbecks Arch Surg       Date:  2016-11-26       Impact factor: 3.445

4.  Adrenocortical carcinoma: presentation and outcome of a contemporary patient series.

Authors:  Iiro Kostiainen; Liisa Hakaste; Pekka Kejo; Helka Parviainen; Tiina Laine; Eliisa Löyttyniemi; Mirkka Pennanen; Johanna Arola; Caj Haglund; Ilkka Heiskanen; Camilla Schalin-Jäntti
Journal:  Endocrine       Date:  2019-04-12       Impact factor: 3.925

Review 5.  Retroperitoneoscopic adrenalectomy in pheochromocytoma.

Authors:  Marcelo Hisano; Fabio Carvalho Vicentini; Miguel Srougi
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.